Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 32.19%4B | 24.93%2.73B | 0.69%1.06B | 27.43%5.54B | 2.10%3.03B | 7.52%2.19B | 79.43%1.05B | 18.09%4.35B | 6.83%2.97B | 0.75%2.03B |
| Refunds of taxes and levies | 16.16%223.39M | 21.98%169.23M | 13.53%73.71M | 44.98%194.18M | 78.72%192.3M | 90.52%138.74M | 80.58%64.92M | -33.86%133.94M | -47.30%107.6M | -47.16%72.82M |
| Cash received relating to other operating activities | -35.67%135.27M | -20.86%108.89M | 13.69%64.76M | -57.29%228.37M | 370.25%210.26M | 239.61%137.6M | 50.66%56.96M | 1,170.52%534.65M | 2.53%44.71M | 56.82%40.52M |
| Cash inflows from operating activities | 27.13%4.36B | 22.21%3.01B | 2.03%1.2B | 18.87%5.97B | 10.02%3.43B | 14.71%2.46B | 77.84%1.18B | 27.76%5.02B | 3.11%3.12B | -1.61%2.15B |
| Goods services cash paid | 34.62%3.25B | 26.72%2.24B | -4.72%757.84M | 35.16%4.53B | 6.96%2.42B | 12.80%1.76B | 122.03%795.36M | 12.72%3.35B | -0.06%2.26B | -5.68%1.56B |
| Staff behalf paid | 11.83%561.47M | 11.62%363.72M | 10.13%180.18M | -4.36%670.6M | 0.69%502.08M | -1.39%325.86M | 2.24%163.6M | 13.72%701.19M | 16.44%498.63M | 13.80%330.44M |
| All taxes paid | -11.53%164.98M | -19.44%111.76M | -24.71%54.98M | -8.21%229.95M | -7.07%186.49M | 5.61%138.73M | 22.35%73.02M | 26.80%250.52M | 33.31%200.66M | 32.84%131.36M |
| Cash paid relating to other operating activities | 19.60%234.81M | 23.09%181.91M | 51.08%152.67M | -63.37%310.74M | 166.48%196.32M | 121.14%147.78M | 106.87%101.05M | 310.19%848.24M | 28.97%73.67M | 30.40%66.83M |
| Cash outflows from operating activities | 27.66%4.22B | 21.73%2.89B | 1.11%1.15B | 11.45%5.74B | 8.87%3.3B | 13.57%2.38B | 80.78%1.13B | 28.97%5.15B | 4.68%3.03B | -0.29%2.09B |
| Net cash flows from operating activities | 13.47%144.92M | 35.37%118.07M | 26.81%53.29M | 268.79%224.34M | 51.18%127.72M | 58.04%87.23M | 23.71%42.02M | -100.39%-132.91M | -32.94%84.48M | -34.41%55.19M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --25K | --25K |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | ---- | ---- | ---- | -34.83%379.85K | 204.91%289.66K | 1,058.64%289.66K | 788.04%222.01K | -88.91%582.85K | -98.59%95K | -99.63%25K |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -25.39%25K | ---- | ---- |
| Cash received relating to other investing activities | 361.47%226.12M | 361.47%226.12M | 259.03%175.93M | -89.79%49M | -97.31%49M | -96.30%49M | -92.69%49M | 1,613.39%479.75M | 421.08%1.82B | 278.40%1.32B |
| Cash inflows from investing activities | 358.76%226.12M | 358.76%226.12M | 257.41%175.93M | -89.72%49.38M | -97.30%49.29M | -96.28%49.29M | -92.66%49.22M | 1,342.95%480.36M | 411.31%1.82B | 271.29%1.32B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -83.54%27.93M | -84.40%14.99M | -86.17%7.9M | -56.95%316.91M | -56.82%169.72M | -64.24%96.09M | -45.13%57.09M | -7.03%736.18M | 10.92%393.07M | 66.93%268.68M |
| Cash paid relating to other investing activities | 500.00%60M | 500.00%60M | --10M | -96.63%10M | -99.31%10M | -98.95%10M | ---- | -19.73%297M | 154.04%1.45B | 171.14%949M |
| Cash outflows from investing activities | -51.07%87.93M | -29.31%74.99M | -68.65%17.9M | -68.36%326.91M | -90.24%179.72M | -91.29%106.09M | -90.53%57.09M | -11.07%1.03B | 99.17%1.84B | 138.32%1.22B |
| Net cash flows from investing activities | 205.95%138.19M | 366.07%151.13M | 2,107.55%158.03M | 49.80%-277.53M | -660.35%-130.43M | -153.20%-56.8M | -111.70%-7.87M | 51.01%-552.82M | 96.98%-17.15M | 169.22%106.77M |
| Financing cash flow | ||||||||||
| Cash from borrowing | -39.02%1.73B | -35.03%1.38B | -22.17%853.74M | -27.34%3.56B | -13.96%2.83B | -22.10%2.12B | -24.85%1.1B | -16.35%4.9B | 52.37%3.29B | -17.75%2.72B |
| Cash received relating to other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -85.16%218.94M | --242.44M |
| Cash inflows from financing activities | -39.02%1.73B | -35.03%1.38B | -22.17%853.74M | -27.34%3.56B | -19.33%2.83B | -28.47%2.12B | -24.85%1.1B | -16.35%4.9B | -3.40%3.51B | -10.43%2.97B |
| Borrowing repayment | -15.50%2.08B | -19.81%1.47B | 3.43%984.01M | -7.52%3.33B | -22.74%2.47B | -29.21%1.83B | -21.51%951.39M | 6.90%3.6B | 114.02%3.19B | 205.31%2.59B |
| Dividend interest payment | -49.32%101.27M | -54.30%79.58M | -21.36%23.08M | -3.53%204.47M | -11.88%199.82M | -10.96%174.14M | -3.69%29.35M | -27.61%211.94M | 22.33%226.74M | 19.47%195.57M |
| Cash payments relating to other financing activities | -53.19%109.89M | -65.49%49.97M | 261.79%49.97M | -89.67%34.59M | 150.12%234.78M | 56.03%144.78M | -87.25%13.81M | -43.12%334.87M | -87.65%93.87M | -85.09%92.79M |
| Cash outflows from financing activities | -20.88%2.3B | -25.67%1.6B | 6.28%1.06B | -13.95%3.57B | -17.42%2.9B | -25.23%2.15B | -26.38%994.55M | -2.41%4.15B | 44.17%3.51B | 76.15%2.88B |
| Net cash flows from financing activities | -738.81%-567.49M | -610.70%-221.59M | -298.53%-203.31M | -101.11%-8.37M | -6,397.41%-67.65M | -135.90%-31.18M | -5.90%102.41M | -53.18%752.63M | -100.09%-1.04M | -94.82%86.85M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -0.75%6.72M | 2.60%6.44M | 37.94%3.74M | 102.50%9.97M | 93.07%6.77M | 105.92%6.28M | 537.29%2.71M | -1.34%4.92M | -7.82%3.51M | 3,128.58%3.05M |
| Net increase in cash and cash equivalents | -336.63%-277.65M | 878.50%54.06M | -91.57%11.74M | -171.83%-51.59M | -191.11%-63.59M | -97.81%5.52M | -33.52%139.27M | -82.81%71.82M | -90.83%69.8M | -84.33%251.86M |
| Add:Begin period cash and cash equivalents | -7.07%677.88M | -7.07%677.88M | -7.07%677.88M | 10.92%729.47M | 10.92%729.47M | 10.92%729.47M | 10.92%729.47M | 174.13%657.65M | 174.13%657.65M | 174.13%657.65M |
| End period cash equivalent | -39.89%400.23M | -0.42%731.94M | -20.62%689.63M | -7.07%677.88M | -8.46%665.88M | -19.19%735M | 0.19%868.74M | 10.92%729.47M | -27.36%727.45M | -50.75%909.51M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.